ArticleOncotarget2015

DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.

Juan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.